Integration of 3-Dimensional Scar Models from SPECT to Guide Ventricular Tachycardia Ablation

The integration of myocardial scar models in 3-dimensional (3D) mapping systems may provide a novel way of helping to guide ventricular tachycardia (VT) ablations. This study assessed the value of 201Tl SPECT perfusion imaging to define ventricular myocardial scar areas and to characterize electrophysiology voltage-derived myocardial substrate categories of scar, border zone (BZ), and normal myocardium regions. Scar and BZ regions have been implicated in the genesis of ventricular arrhythmias. Methods: Ten patients scheduled for VT ablation underwent 201Tl SPECT before the ablation procedure. 3D left ventricular (LV) scar models were created from the SPECT images. These scar models were registered with the LV voltage maps and analyzed with a 17-segment cardiac model. Scar location and scar burden were compared between the SPECT scar models and voltage maps. In addition, 201Tl SPECT uptake was quantified using a 68-segment cardiac model and compared among voltage-defined scar, BZ, and normal segments. Results: 3D models of LV myocardium and scar were successfully created from 201Tl SPECT images and integrated in a clinical mapping system. The surface registration error with the electrophysiology voltage map was 4.4 ± 1.0 mm. The 3D scar location from SPECT matched in 72% of the segments with the voltage map findings. All successful ablation sites were located within the SPECT-defined scar or within 1 cm of its border, with 73% of the successful ablation sites within 1 cm of the scar border. Voltage measurements in SPECT-defined scar and normal areas were 1.2 ± 1.7 and 3.4 ± 2.8 mV, respectively (P < 0.001). The fractional SPECT scar burden area (18.8% ± 5.2%) agreed better with the abnormal (scar plus BZ) voltage area (20.8% ± 15.7%) than with the scar voltage area (5.8% ± 5.8%). Mean normalized 201Tl uptake was 55% ± 21% in the voltage-defined scar, 63% ± 20% in BZ, and 79% ± 17% in normal myocardial segments (P < 0.05 for scar or BZ vs. normal). Conclusion: 3D SPECT surface models of LV scar were accurately integrated into a clinical mapping system and predicted endocardial voltage-defined scar. These preliminary data support the possible use of widely available 201Tl SPECT to facilitate substrate-guided VT ablations.

[1]  M. Perazella,et al.  Current status of gadolinium toxicity in patients with kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[2]  D. Wilber,et al.  Substrate-based endocardial ablation of postinfarction ventricular tachycardia. , 2006, Heart rhythm.

[3]  Katja Zeppenfeld,et al.  Head-to-head comparison of contrast-enhanced magnetic resonance imaging and electroanatomical voltage mapping to assess post-infarct scar characteristics in patients with ventricular tachycardias: real-time image integration and reversed registration. , 2011, European heart journal.

[4]  Riemer H. J. A. Slart,et al.  Imaging Techniques in Nuclear Cardiology for the Assessment of Myocardial Viability , 2005, The International Journal of Cardiovascular Imaging.

[5]  O. Faris,et al.  Food and Drug Administration perspective: Magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. , 2006, Circulation.

[6]  H. Schelbert,et al.  Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  Katsuya Yoshida,et al.  Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization. , 1993, Journal of the American College of Cardiology.

[8]  Raj Shekhar,et al.  Integration of three-dimensional scar maps for ventricular tachycardia ablation with positron emission tomography-computed tomography. , 2008, JACC. Cardiovascular imaging.

[9]  M. Phelps,et al.  Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. , 1993, Circulation.

[10]  Timm Dickfeld,et al.  MRI-Guided Ventricular Tachycardia Ablation: Integration of Late Gadolinium-Enhanced 3D Scar in Patients With Implantable Cardioverter-Defibrillators , 2011, Circulation. Arrhythmia and electrophysiology.

[11]  Warren M. Jackman,et al.  Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial Infarction: The Multicenter Thermocool Ventricular Tachycardia Ablation Trial , 2008, Circulation.

[12]  Chenyang Xu,et al.  Clinical Application of PET/CT Fusion Imaging for Three‐Dimensional Myocardial Scar and Left Ventricular Anatomy during Ventricular Tachycardia Ablation , 2009, Journal of cardiovascular electrophysiology.

[13]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[14]  David O. Martin,et al.  Relationship Between Successful Ablation Sites and the Scar Border Zone Defined by Substrate Mapping for Ventricular Tachycardia Post‐Myocardial Infarction , 2005, Journal of cardiovascular electrophysiology.

[15]  Raj Shekhar,et al.  Three-Dimensional Contrast-Enhanced Multidetector CT for Anatomic, Dynamic, and Perfusion Characterization of Abnormal Myocardium To Guide Ventricular Tachycardia Ablations , 2010, Circulation. Arrhythmia and electrophysiology.

[16]  F. Marchlinski,et al.  Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. , 2000, Circulation.

[17]  Jeroen J. Bax,et al.  Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.